FINWIRES · TerminalLIVE
FINWIRES

欧洲、中东和非洲地区天然气市场最新动态:受伊朗霍尔木兹海峡重新开放天然气供应协议影响,天然气价格下跌

By

-- 周一盘后交易中,欧洲天然气期货价格小幅走低,此前有报道称,伊朗提议以美国解除封锁为条件,重新开放霍尔木兹海峡。 荷兰TTF天然气近月合约下跌0.92%,至每兆瓦时44.45欧元(52.14美元);英国NBP基准天然气合约下跌1.48%,至每热量单位110.25便士(1.49美元)。 媒体报道称,伊朗提出,如果华盛顿解除经济和军事压力并同意停止敌对行动,伊朗将解除对霍尔木兹海峡过境的限制。据报道,该提议将推迟有关伊朗核计划的谈判。 此前,原定于周末在巴基斯坦举行的第二轮美伊和平谈判未能如期举行。 霍尔木兹海峡是全球液化天然气运输的重要通道,约占全球液化天然气运输量的五分之一,目前已连续九周处于关闭状态。然而,根据霍尔木兹海峡监测报告,过去24小时内有19艘船舶通过该海峡,表明船舶通行量有所增加。 卡塔尔的基础设施受损加剧了供应方面的担忧。国际能源署周五警告称,中断可能导致一项大型液化天然气扩建项目至少延期两年,并可能在2026年至2030年间使市场供应减少1200亿立方米。 该机构表示:“虽然其他地区的新液化项目有望随着时间的推移弥补这些损失,但此次事件的影响将使市场供应紧张的局面持续到2026年和2027年。” 与此同时,欧洲天然气库存水平仍然面临压力。据欧洲天然气基础设施协会(Gas Infrastructure Europe)的数据,库存占总容量的31.47%,而去年同期为38.14%。 Timera Energy表示,4月份的低库存水平意味着,即使将库存目标下调至80%,欧洲也需要达到与去年夏季类似的注入速度。尽管目前缓慢的注入速度有助于稳定全球价格,但该公司警告称,未来几个月可能需要持续增产。 蒂梅拉表示,如果中东紧张局势不能迅速解决,欧洲可能需要积极竞购液化天然气货物以确保供应,这可能会推高价格,并导致部分货物从亚洲买家手中转移。

Related Articles

Insider Trading

Lifestance Health Group Insider Sold Shares Worth $492,400, According to a Recent SEC Filing

Robert Bessler, Director, on April 23, 2026, sold 69,899 shares in Lifestance Health Group (LFST) for $492,400. Following the Form 4 filing with the SEC, Bessler has control over a total of 1,485,228 common shares of the company, with 57,619 shares held directly and 1,427,609 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526182153/xslF345X05/ownership.xml

$LFST
Australia

Celestica Q1 Adjusted Earnings, Revenue Rise; Q2 Guidance Set

Celestica (CLS) reported Q1 adjusted earnings late Monday of $2.16 per diluted share, up from $1.20 a year earlier.Analysts polled by FactSet expected $2.07.Revenue for the three months ended March 31 was $4.05 billion, up from $2.65 billion a year earlier.Analysts surveyed by FactSet expected $4.04 billion.For Q2, the company expects adjusted EPS of $2.14 to $2.34 on revenue of $4.15 billion to $4.45 billion. Analysts expect EPS of $2.13 on revenue of $4.17 billion.The company now expects 2026 adjusted EPS of $10.15 on revenue of $19 billion, revised from $8.75 and $17 billion, respectively, expected earlier. Analysts expect EPS of $8.93 on revenue of $17.34 billion.

$CLS
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Ameriprise Financial, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month target price of $550, valuing AMP shares at 12.5x our 2026 adjusted EPS estimate of $43.84 (raised by $1.34) and at 11.7x our 2027 EPS estimate of $46.90 (raised by $0.70). This compares to the three-year average forward multiple of 12x and peer average of 15.5x. AMP posted Q1 2026 adjusted operating EPS of $11.26 vs. $9.50, a 19% rise that topped our $10.12 estimate and $10.21 consensus view. Revenue growth of 11% exceeded our forecast and our 6%-10% growth forecast for 2026, while pretax adjusted operating margins expanded 130 bps to 28% on revenue gains and cost containment efforts. We now see revenue growth of 7% to 12% in 2026 and 2027. AMP also continued its substantial capital return program, returning $936M to shareholders in Q1 (70% of adjusted operating earnings) and $3.4B in 2025 (88% of earnings). Currently trading at 10.9x our 2026 EPS estimate, and with some decent revenue and earnings momentum, we view the shares as undervalued versus peer and historical averages.

$AMP